I worked with Cycle Pharmaceuticals to develop a new identity for ORMALVI, a treatment for Primary Periodic Paralysis (PPP), a rare genetic disorder that causes sudden episodes of extreme muscle weakness, stiffness and temporary paralysis. I designed the logo, guidelines and supporting materials.
